Advances in Endovascular Treatment of CLTI: Insights From the LIFE-BTK Trial

CME credit is now available for those who registered and attended the live webinar. You should have received an email from contact@viva-foundation.org, please check your spam and junk folders. If you did not receive an email, please contact cebbe@viva-foundation.org. Credit must be claimed by Monday, April 15.

The webinar recording will be available next week.

Co-Moderators
Ehrin Armstrong, MD & Niten Singh, MD

Speakers & panel
Brian DeRubertis, MD; Elizabeth Genovese, MD; Raghu Kolluri, MD, MS; Misti Malone, PhD; Sahil A. Parikh, MD; Mahmood Razavi, MD;
Ramon Varcoe, MBBS, MS, PhD

Agenda

LIFE-BTK Results
Brian DeRubertis, MD

Evolving Endpoints, Trial Designs, and Results for Future BTK Trials
Sahil A. Parikh, MD

The Landscape of Emerging Bioresorbable Scaffold Technology
Ramon Varcoe, MBBS, MS, PhD

Wound Outcomes in LIFE-BTK
Raghu Kolluri, MD, MS

Potential Impact of the LIFE-BTK Results on Practice
Mahmood Razavi, MD

The Impact of Clinical Outcomes vs Device Patency for Approval
Misti Malone, PhD

Accreditation

Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and the VIVA Foundation (VIVA). Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians (ACCME)
Amedco LLC designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician assistants, nurse practitioners, and nurses may participate in this educational activity and earn a certificate of completion as AAPA, AANP, and ANCC accept AMA PRA Category 1 CreditsTM through their reciprocity agreements.

Learning Objectives

  • Describe the results of scaffold therapy in the below-the-knee space
  • Describe approaches for below-the-knee disease and wound outcomes
  • Describe the existing hurdles for trials for below-the-knee treatments